Ignite Creation Date:
2024-05-06 @ 3:23 AM
Last Modification Date:
2024-10-26 @ 11:32 AM
Study NCT ID:
NCT02273349
Status:
WITHDRAWN
Last Update Posted:
2017-05-02
First Post:
2014-10-21
Brief Title:
Lung Volume Reduction Coils for Emphysema in Alpha-1 Antitrypsin Deficiency
Sponsor:
University Hospital Saarland
Organization:
University Hospital Saarland
Study Overview
Official Title:
Evaluation of the PneumRx Inc Lung Volume Reduction Coil for the Treatment of Emphysema in Alpha-1 Antitrypsin Deficient Patients
Status:
WITHDRAWN
Status Verified Date:
2017-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
LuReCAA
Brief Summary:
The objective of this study is to evaluate the safety and effectiveness of the RePneu Lung Volume Reduction Coil LVRC in patients with Alpha-1-Antitrypsin deficiency AATD caused emphysema The hypothesis is that emphysema in AATD patients shows similar tissue destruction profile was well as symptoms and thus will respond favorably to LVRC treatment demonstrating improvement in lung function exercise capacity and quality of life relative to their baseline status
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None